S1766 Predictive Value of Intestinal Ultrasound for Treatment Response and Long-Term Outcomes in Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis

Introduction: Intestinal ultrasound (IUS) is an emerging non-invasive modality for real-time monitoring in ulcerative colitis (UC). Its role in predicting treatment response and long-term outcomes in severe UC remains underexplored. Objective: To evaluate the accuracy of IUS - particularly bowel wall thickness (BWT), in predicting treatment response and future outcomes in patients with severe UC. Methods: A comprehensive electronic search was conducted on Medline, Embase and Cochrane through December 2024 to identify prospective cohort studies and randomized controlled trials (RCTs). Primary outcome was the predictive accuracy of ≥20% reduction in bowel wall thickness. Secondary outcomes included colectomy rates and steroid response using BWT thresholds (<1–2 mm reduction). Diagnostic test accuracy (DTA) data were synthesized using a bivariate random-effects model (Meta-DiSc 2.0). Odds ratios (ORs) for predictors of nonresponse were pooled using a random-effects model (RevMan 5.4.1). Results: Four studies were included from 5403 citations reporting outcomes in terms of steroid response and/or need for colectomy. Meta-analysis of 2 studies assessing a ≥20% reduction in BWT showed a sensitivity of 0.83 (95% CI 0.67–0.92) and specificity of 0.77 (95% CI 0.64–0.87) for predicting steroid response. Positive and negative likelihood ratios were 3.66 (95% CI: 1.76–5.56) and 0.22 (95% CI: 0.06–0.39), respectively, indicating strong rule-in and rule-out utility. One study reported that BWT >4.0 mm was associated with an OR of 9.5 (95% CI: 1.5–186) for colectomy at 3 months. A BWT reduction < 2 mm was associated with an OR of 3.8 (95% CI: 0.6–75) for colectomy. Conclusion: IUS, particularly BWT assessment, demonstrates promising diagnostic accuracy for predicting steroid response in severe UC and may aid in early identification of patients at risk of treatment failure. Although early data suggest potential in predicting colectomy risk, current evidence is limited by heterogeneity and small sample sizes. Larger, prospective studies are needed to confirm the utility of IUS in long-term risk stratification and treatment optimization.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001134524.44859.a8
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1766 Predictive Value of Intestinal Ultrasound for Treatment Response and Long-Term Outcomes in Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis

Natalia Causada Calo, Siwar Albashir, Sunil Samnani, Dorota Borovsky et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

S1766 Predictive Value of Intestinal Ultrasound for Treatment Response and Long-Term Outcomes in Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis

Natalia Causada Calo, Siwar Albashir, Sunil Samnani, Dorota Borovsky, Mohammad Yaghoobi, Moneer Mohammed
article en

Abstract

Introduction: Intestinal ultrasound (IUS) is an emerging non-invasive modality for real-time monitoring in ulcerative colitis (UC). Its role in predicting treatment response and long-term outcomes in severe UC remains underexplored. Objective: To evaluate the accuracy of IUS - particularly bowel wall thickness (BWT), in predicting treatment response and future outcomes in patients with severe UC. Methods: A comprehensive electronic search was conducted on Medline, Embase and Cochrane through December 2024 to identify prospective cohort studies and randomized controlled trials (RCTs). Primary outcome was the predictive accuracy of ≥20% reduction in bowel wall thickness. Secondary outcomes included colectomy rates and steroid response using BWT thresholds (<1–2 mm reduction). Diagnostic test accuracy (DTA) data were synthesized using a bivariate random-effects model (Meta-DiSc 2.0). Odds ratios (ORs) for predictors of nonresponse were pooled using a random-effects model (RevMan 5.4.1). Results: Four studies were included from 5403 citations reporting outcomes in terms of steroid response and/or need for colectomy. Meta-analysis of 2 studies assessing a ≥20% reduction in BWT showed a sensitivity of 0.83 (95% CI 0.67–0.92) and specificity of 0.77 (95% CI 0.64–0.87) for predicting steroid response. Positive and negative likelihood ratios were 3.66 (95% CI: 1.76–5.56) and 0.22 (95% CI: 0.06–0.39), respectively, indicating strong rule-in and rule-out utility. One study reported that BWT >4.0 mm was associated with an OR of 9.5 (95% CI: 1.5–186) for colectomy at 3 months. A BWT reduction < 2 mm was associated with an OR of 3.8 (95% CI: 0.6–75) for colectomy. Conclusion: IUS, particularly BWT assessment, demonstrates promising diagnostic accuracy for predicting steroid response in severe UC and may aid in early identification of patients at risk of treatment failure. Although early data suggest potential in predicting colectomy risk, current evidence is limited by heterogeneity and small sample sizes. Larger, prospective studies are needed to confirm the utility of IUS in long-term risk stratification and treatment optimization.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.